机读格式显示(MARC)
- 000 02525cam a2200409 i 4500
- 008 190603s2019 si a b 001 0 eng d
- 020 __ |z 9789811387470 |q electronic book
- 020 __ |z 9811387478 |q electronic book
- 040 __ |a UPM |b eng |c UPM |e rda |d OCLCO |d EBLCP |d YDX |d GW5XE |d UAB |d YDXIT |d UKMGB |d OCLCQ |d OCLCF |d VT2 |d CEF |d LVT |d LEATE |d OCLCQ |d UKAHL |d SFB
- 050 _4 |a QD431 |b .L36 2019
- 099 __ |a CAL 022021088903
- 100 1_ |a Langel, Ulo, |e author.
- 245 10 |a CPP, cell-penetrating peptides / |c Ulo Langel.
- 264 _1 |a Singapore : |b Springer, |c [2019]
- 300 __ |a xii, 470 pages : |b illustrations (some color) ; |c 24 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 504 __ |a Includes bibliographical references and index.
- 505 0_ |a Classes and applications of CPP -- CPP functionalization -- Protein delivery and mimicry -- Targeting strategies -- Methods for detection and visualization of CPPs -- Methods for structural studies of CPPs -- Kinetics -- Toxicity and immune response -- Cell-translocation mechanisms of CPPs -- Clinical trials and commercialization using CPPs -- Therapeutic potential of CPPs.
- 520 __ |a In this book, a summary and update of the most important areas of CPP research are presented, whilst raising relevant questions for further development. The CPP sequences are presented and discussed throughout the book. The methods for testing CPP mechanisms are discussed in detail. Various approaches for the testing of endocytotic pathways of CPP uptake are also described. Different CPP uptake experiments are compared since it is becoming clear that it is often best to apply several methods in a complementary manner in order to most comprehensively evaluate CPP uptake mechanisms due to the complexity of these processes. A brief summary of functionality issues of CPPs, both in vitro and in vivo are discussed. Therapeutic potential of CPPs and commercial developments are discussed. The monograph is written for researchers and students in the field.
- 650 12 |a Cell-Penetrating Peptides |x pharmacokinetics.
- 650 22 |a Cell-Penetrating Peptides |x therapeutic use.